It has been shown previously that either Mcl-1 downregulation or NOXA overexpression, an Mcl-1 specific BH3-only protein, strongly sensitizes melanoma cells to ABT-737 in vitro[7]. This evidence concerns the gene PMAIP1 and melanoma.